Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S29 pseudogene 20 is a **pseudogene** derived from the gene encoding ribosomal protein S29 (RPS29), which itself is a component of the small (40S) ribosomal subunit and participates in protein synthesis[1][3][6]. Pseudogenes such as RPS29P20 arise from genomic duplications or retrotransposition events and do not produce functional protein products[8]. There is no current evidence that RPS29P20 encodes a functional protein, plays a role in disease, is a drug target, or has established clinical significance. It should not be confused with the functional RPS29 gene, mutations of which are implicated in diseases such as Diamond-Blackfan anemia[4][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S29 pseudogene 20 (RPS29P20).